Search

Your search keyword '"TURNER, SUZANNE"' showing total 799 results

Search Constraints

Start Over You searched for: Author "TURNER, SUZANNE" Remove constraint Author: "TURNER, SUZANNE"
799 results on '"TURNER, SUZANNE"'

Search Results

51. Motherhood, medicine and cancer

52. Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma

54. P1235: INVESTIGATION OF THE CO-MUTATIONAL LANDSCAPE OF ALK-POSITIVE ALCL

55. Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma

56. Patient‐derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinib

61. The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma

63. Supplementary material from Developing the WCRF International/University of Bristol Methodology for Identifying and Carrying Out Systematic Reviews of Mechanisms of Exposure–Cancer Associations

64. Data from Developing the WCRF International/University of Bristol Methodology for Identifying and Carrying Out Systematic Reviews of Mechanisms of Exposure–Cancer Associations

67. Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma

68. The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status

69. The Pioneer platform: A novel approach for selection of selective anti-cancer cytotoxic activity in bacteria through co-culturing with engineered human cells

70. Correction: Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma

71. Response to: What Is Missing From the 2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCL?

73. Effective and Safe Immune Checkpoint Blockade Induces Complete Responses in Murine PTCL Model of ALCL

74. Evaluating the baseline survival outcomes of the “six Global Initiative for Childhood Cancer index cancers” in Africa

75. Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers collateral sensitivity to ALK inhibitors in high-risk neuroblastoma

77. TP53 STATUS RISK STRATIFIES PATIENTS WITH CLINICALLY DEFINED HIGH-RISK DISEASE PAEDIATRIC B-CELL NON-HODGKIN LYMPHOMA

78. STAT3 cooperates with the core transcriptional regulatory circuitry to drive MYC expression and oncogenesis in anaplastic large cell lymphoma

83. STAT3 restricts prostate cancer metastasis and antiandrogen resistance by controlling LKB1/CREB signaling pathway

85. Abstract 5344: High-throughput CRISPR-Cas9 knockout screens identify loss of miRNA1304-5p targeting the RAS/MAPK pathway as a modulator of resistance to ALK inhibitors in high-risk neuroblastoma

88. Evaluating the baseline survival outcomes of the "six Global Initiative for Childhood Cancer index cancers" in Africa.

89. The Association of Breastfeeding Duration and Early Childhood Cardiometabolic Risk

90. 2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCL

92. To Waste or Not to Waste: Questioning Potential Health Risks of Micro- and Nanoplastics with a Focus on Their Ingestion and Potential Carcinogenicity

93. Additional file 1 of KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis

94. Additional file 2 of KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis

95. The role of autophagy and lncRNAs in the maintenance of cancer stem cells

99. Paediatric Burkitt lymphoma patient-derived xenografts capture disease characteristics over time and are a model for therapy

Catalog

Books, media, physical & digital resources